Fendx Technologies, Inc. · CSE:FNDX
Fendx Technologies — Investor Presentation (September 2025)
18 slides from Fendx Technologies's investor presentation, Sep 20, 2025
Slide 1: Committed to Safer Surfaces and Safer Lives
C o m m i tte d to S a fe r S u r fa c e s a n d S a fe r L i ve s CSE: FNDX | OTCQB: FDXTF | FSE: E8D SEPTEMBER 2025
Slide 2: Forward Looking Statement
FORWARD LOOKING STATEMENT: This presentation contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; expectations regarding industry trends, including with respect to the antimicrobial surface coating, an
Slide 3: Developing Advanced Technologies for Surface Hygiene
Developing Advanced Technologies for Surface Hygiene Nano-Coatings AI-Diagnostic Nano-coatings to protect Applying AI to mobile high-touch surfaces, device images to detect catheters and potentially surface contamination in other medical devices real-time CSE: FNDX | OTCQB: FDXTF | FSE:E8D SEPTEMBER
Slide 4: Addressing the Challenge of Surface Contamination
Addressing the Challenge of Surface Contamination The Problem The Solution • Rise in antibiotic resistance (AMR) pathogens a • FendX is focused on innovating solutions to global issue1 support healthcare and public spaces through targeted surface protection • AMR could surpass cancer as leading caus
Slide 5: AI-Powered Microbial Surface Contamination Detection
AI-Powered Microbial Surface Contamination Detection Snap a Photo – Know Its Clean
Slide 6: AI Platform to Detect Microbial Contamination On Surfaces
AI Platform to Detect Microbial Contamination On Surfaces by Analyzing Mobile Device Images on Demand Surface Microbial AI Detection Can Contamination is: Provide: Microbial contamination on high-touch surfaces can pose health risks CSE: FNDX | OTCQB: FDXTF | FSE:E8D SEPTEMBER 2025/ 6
Slide 7: Developing Software Using Microbial Imaging to Assess Surface Contamination via a Mobile Device
Developing Software Using Microbial Imaging to Assess Surface Contamination via a Mobile Device Verify Clean Capture Image AI Analysis Microbial Contaminated Contamination Surface o AI-powered software analyzes images to determine presence of microbial contamination o Beta-testing to validate app’s
Slide 8: Advanced Nano-Coatings
Advanced Nano-Coatings PROTECTING SURFACES FROM MICROBIAL THREATS
Slide 9: Antimicrobial & Antiviral Surface Nano-Coating: A Significant Opportunity
Antimicrobial & Antiviral Surface Nano-Coating: A Significant Opportunity Estimated global market revenue in 2031 (USD) 1 ~$1.85 Bn ~ 8% CAGR (2024-2031) FendX has signed LOI with Sources: 1. https://www.futuremarketsinc.com/the-global-market-for-antimicrobial-antiviral-and-antifungal- Sinelabs to d
Slide 10: Nanoparticle-Infused Liquid Coating For Lasting Surface Protection
Nanoparticle-Infused Liquid Coating For Lasting Surface Protection • 99% reduction in MRSA and Pseudomonas aeruginosa 1 • Easy application with brush, roller or sprayer to apply on high-touch surfaces • Durable protection for long-lasting pathogen control • Currently finalizing formulation and prepa
Slide 11: REPELWRAP Film
Adhesive backing for application REPELWRAP Film on high touch surfaces Nano-Coated Film to Protect Flat Surfaces • >98% reduction in adhesion of a Covid-19 like virus, E. coli, B. subtilis and MRSA1,2 • Intermediate scale-up manufacturing confirmed with Dunmore* • Currently in beta-testing; results
Slide 12: Foley Catheter Lubricant-Coating For Infection Prevention
Foley Catheter Lubricant-Coating For Infection Prevention Reducing CAUTIs* Through Advanced Surface Coating Technology Estimated global market • ~560,000 CAUDIs occur annually in the U.S., revenue in 2033 (USD)4 costing ~$340 M in healthcare cost1,2 • 95% reduction in biofilm formation3 • Currently
Slide 13: Building A Robust Patent Portfolio
Building A Robust Patent Portfolio Omniphobic Surfaces with Hierarchical Structures, and AI Adaptive App (Triple A) Pathogen Detection Methods of Making and Uses Thereof Platform • Chinese Patent Application # ZL 202080055337.6 - granted • US Provisional Patent Application # 63/835,582 • US Patent A
Slide 14: Proven Management Team
Proven Management Team Dr. Carolyn Myers MBA, PhD Rose Zanic CPA, CA Tash Yousuf BSc President, CEO & Director CFO & Corporate Secretary Sr. Operations Manager • Accomplished senior pharma executive with • Over 25 years of capital markets and • Expertise in project and operations extensive experienc
Slide 15: Board of Directors & Advisors
Board of Directors & Advisors Stephen Randall CPA, CGA • Senior financial manager and Director with over 40 years’ experience. • Served in senior financial roles with both private, publicly traded and start-up companies in the Independent Board Member manufacturing, telecommunications, technology, a
Slide 16: FendX Share Capital
FendX Share Capital Shares outstanding 9,001,969 Options 941,667 RSUs 28,750 Warrants 2,466,796 Fully diluted 12,439,182 September 10, 2025 CSE: FNDX | OTCQB: FDXTF | FSE:E8D SEPTEMBER 2025/ 16
Slide 17: A Leader in Surface Protection
A Leader in Surface Protection • Advanced Nano-Coating and AI Solutions: developing advanced coatings and detection technologies to combat against microbial contamination • Robust IP Portfolio: 6 granted patents with more in the pipeline; securing a strong competitive edge • High Growth Market Poten
Slide 18: Thank You!
Thank You! investor@fendxtech.com / fendxtech.com CSE: FNDX | OTCQB: FDXTF | FSE: E8D SEPTEMBER 2025
FendX Technologies — Investor Presentation (September 2025) on 6ix